Martyn Jacobs
Stock Analyst at Bell Potter
(0.04)
# 4,798
Out of 5,081 analysts
214
Total ratings
16.6%
Success rate
-20.7%
Average return
Main Sectors:
Stocks Rated by Martyn Jacobs
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: AYA Artrya Limited | Reiterated: Buy | $6.00 → $4.30 | $2.45 | +75.51% | 8 | Oct 26, 2026 | |
| ASX: BIO Biome Australia Limited | Reiterated: Buy | $0.75 | $0.37 | +105.48% | 21 | Oct 26, 2026 | |
| ASX: EMV EMVision Medical Devices Ltd | Reiterated: Buy | $3.15 | $1.52 | +107.24% | 11 | Oct 26, 2026 | |
| ASX: AHC Austco Healthcare Limited | Reiterated: Buy | $0.45 → $0.50 | $0.28 | +76.99% | 6 | Oct 20, 2026 | |
| ASX: MVP Medical Developments International Limited | Reiterated: Buy | $1.00 | $0.37 | +173.97% | 17 | Oct 15, 2026 | |
| ASX: EBR EBR Systems, Inc. | Reiterated: Buy | $0.70 → $0.20 | $0.13 | +53.85% | 22 | Oct 13, 2026 | |
| ASX: MVF Monash IVF Group Limited | Reiterated: Hold | $0.77 → $0.75 | $0.71 | +5.63% | 9 | Aug 31, 2026 | |
| ASX: ONE Oneview Healthcare PLC | Reiterated: Buy | $0.42 | $0.15 | +189.66% | 11 | Aug 31, 2026 | |
| ASX: LDX Lumos Diagnostics Holdings Limited | Reiterated: Buy | $0.25 | $0.07 | +262.32% | 4 | Aug 28, 2026 | |
| ASX: TRJ Trajan Group Holdings Limited | Reiterated: Buy | $0.75 → $0.50 | $0.26 | +90.48% | 16 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.01 | $0.00 | +150.00% | 16 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.60 → $3.15 | $2.10 | +50.00% | 9 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28.75 → $27.50 | $18.99 | +44.81% | 7 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.15 | $2.44 | +111.07% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.009 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.017 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.035 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.42 | n/a | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.12 | n/a | 12 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.073 | n/a | 4 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.045 | n/a | 7 | Oct 31, 2022 |
Artrya Limited
Oct 26, 2026
Reiterated: Buy
Price Target: $6.00 → $4.30
Current: $2.45
Upside: +75.51%
Biome Australia Limited
Oct 26, 2026
Reiterated: Buy
Price Target: $0.75
Current: $0.37
Upside: +105.48%
EMVision Medical Devices Ltd
Oct 26, 2026
Reiterated: Buy
Price Target: $3.15
Current: $1.52
Upside: +107.24%
Austco Healthcare Limited
Oct 20, 2026
Reiterated: Buy
Price Target: $0.45 → $0.50
Current: $0.28
Upside: +76.99%
Medical Developments International Limited
Oct 15, 2026
Reiterated: Buy
Price Target: $1.00
Current: $0.37
Upside: +173.97%
EBR Systems, Inc.
Oct 13, 2026
Reiterated: Buy
Price Target: $0.70 → $0.20
Current: $0.13
Upside: +53.85%
Monash IVF Group Limited
Aug 31, 2026
Reiterated: Hold
Price Target: $0.77 → $0.75
Current: $0.71
Upside: +5.63%
Oneview Healthcare PLC
Aug 31, 2026
Reiterated: Buy
Price Target: $0.42
Current: $0.15
Upside: +189.66%
Lumos Diagnostics Holdings Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $0.25
Current: $0.07
Upside: +262.32%
Trajan Group Holdings Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $0.75 → $0.50
Current: $0.26
Upside: +90.48%
Aug 27, 2026
Reiterated: Buy
Price Target: $0.01
Current: $0.00
Upside: +150.00%
Aug 26, 2026
Reiterated: Buy
Price Target: $3.60 → $3.15
Current: $2.10
Upside: +50.00%
Aug 20, 2026
Reiterated: Buy
Price Target: $28.75 → $27.50
Current: $18.99
Upside: +44.81%
Aug 5, 2026
Reiterated: Buy
Price Target: $5.15
Current: $2.44
Upside: +111.07%
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.009
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.017
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.035
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $2.42
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $3.12
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.073
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.045
Upside: n/a